Page last updated: 2024-11-04

s-methylisothiopseudouronium and Nasopharyngeal Carcinoma

s-methylisothiopseudouronium has been researched along with Nasopharyngeal Carcinoma in 1 studies

S-methylisothiopseudouronium: inhibits nitric oxide synthase; structure in first source

Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.

Research Excerpts

ExcerptRelevanceReference
" SMT can inhibit CNE-2 cells growth in a dose-dependent manner and have the effect on reducing dosage of DDP as well as enhancing the anti-tumor efficacy by promote cell apoptosis."1.40Inducible nitric oxide inhibitor enhances the anti-tumor effect of cisplatin on CNE-2 cells by inducing cell apoptosis. ( Deng, C; Feng, YQ; Hu, CH; Liu, OS; Liu, XL; Tang, ZG; Wang, JJ; Wu, F; Zhang, HX, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, HX1
Deng, C1
Liu, OS1
Liu, XL1
Wu, F1
Wang, JJ1
Feng, YQ1
Hu, CH1
Tang, ZG1

Other Studies

1 other study available for s-methylisothiopseudouronium and Nasopharyngeal Carcinoma

ArticleYear
Inducible nitric oxide inhibitor enhances the anti-tumor effect of cisplatin on CNE-2 cells by inducing cell apoptosis.
    European review for medical and pharmacological sciences, 2014, Volume: 18, Issue:19

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Prolife

2014